Loading...
Loseolamycins: A Group of New Bioactive Alkylresorcinols Produced after Heterologous Expression of a Type III PKS from micromonospora endolithica.
Lasch, Constanze Gummerlich, Nils Myronovskyi, Maksym Palusczak, Anja Zapp, Josef Luzhetskyy, Andriy
Lasch, Constanze
Gummerlich, Nils
Myronovskyi, Maksym
Palusczak, Anja
Zapp, Josef
Luzhetskyy, Andriy
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-10-09
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 945.91 KB
Other Titles
Abstract
Natural products are a valuable source of biologically active compounds with potential applications in medicine and agriculture. Unprecedented scaffold diversity of natural products and biocatalysts from their biosynthetic pathways are of fundamental importance. Heterologous expression and refactoring of natural product biosynthetic pathways are generally regarded as a promising approach to discover new secondary metabolites of microbial origin. Here, we present the identification of a new group of alkylresorcinols after transcriptional activation and heterologous expression of the type III polyketide synthase of Micromonospora endolithica. The most abundant compounds loseolamycins A1 and A2 have been purified and their structures were elucidated by NMR. Loseolamycins contain an unusual branched hydroxylated aliphatic chain which is provided by the host metabolism and is incorporated as a starter fatty acid unit. The isolated loseolamycins show activity against gram-positive bacteria and inhibit the growth of the monocot weed Agrostis stolonifera in a germination assay. The biosynthetic pathway leading to the production of loseolamycins is proposed in this paper.
Citation
Molecules. 2020 Oct 9;25(20):4594. doi: 10.3390/molecules25204594.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
1420-3049
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution-NonCommercial-ShareAlike 4.0 International